NCT04933552View on ClinicalTrials.gov

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

RecruitingOBSERVATIONAL
Enrollment

867

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

May 31, 2032

Study Completion Date

May 31, 2032

Conditions
Multiple Sclerosis
Interventions
OTHER

Siponimod

Prospective observational cohort study. There is no treatment allocation. Patients administered siponimod, that have started before inclusion of the patient into the study will be enrolled.

Trial Locations (1)

92093-0934

RECRUITING

Novartis Investigative Site, La Jolla

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY